ARTICLE | Company News
Progenics other research news
April 18, 1994 7:00 AM UTC
The Tarrytown, N.Y., company received a $500,000 Phase II SBIR from the National Institute of Allergy and Infectious Diseases to further develop ProSys. The technology, which detects viral entry throu...